Sentencing Law and Policy: Fourth Circuit to review en banc recent panel ruling that lengthy (within-guideline) drug sentence was unreasonable
en banc recent panel ruling that lengthy (within-guideline) drug sentence was unreasonable US v. Freeman, No. 19-4104 (4th Cir. Mar. 30, 2021) (available here), which started this way: Precias Freeman broke her tailbone as a teenager, was prescribed opioids, and has been addicted to the drugs ever since. In 2018, she was sentenced to serve more than 17 years in prison for possession with intent to distribute hydrocodone and oxycodone in violation of 21 U.S.C. §§ 841(a)(1) and 841(b)(1)(C). After Freeman’s appointed counsel initially submitted an Anders brief asking for the Court’s assis...
Source: typepad.com